[Form 4] Hims & Hers Health, Inc. Insider Trading Activity
Insider Trade Summary
Exercise and Sale: 125,335 shares ($5.90M approx. pre-tax spread)
Exercise and Sale
22 txns
Insider
Dudum Andrew
Role
Chief Executive Officer
Sold
125,335 shs ($6.21M)
Approx. gross sale proceeds
$6.21M
Approx. exercise cost
$305K
Approx. pre-tax spread
$5.90M
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (right to buy) | 17,001 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) | 16,667 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) | 41,667 | $0.00 | $0.00 |
| Exercise | Stock Option (right to buy) | 50,000 | $0.00 | $0.00 |
| Exercise | Class A Common Stock | 17,001 | $2.43 | $41K |
| Sale | Class A Common Stock | 17,001 | $49.4252 | $840K |
| Exercise | Class A Common Stock | 16,667 | $2.43 | $41K |
| Sale | Class A Common Stock | 16,667 | $49.4137 | $824K |
| Exercise | Class A Common Stock | 41,667 | $2.43 | $101K |
| Sale | Class A Common Stock | 41,667 | $49.5559 | $2.06M |
| Exercise | Class A Common Stock | 50,000 | $2.43 | $122K |
| Sale | Class A Common Stock | 50,000 | $49.5987 | $2.48M |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
| holding | Class A Common Stock | -- | -- | -- |
Holdings After Transaction:
Stock Option (right to buy) — 824,405 contracts (Direct);
Class A Common Stock — 92,313 shares (Direct);
Class A Common Stock — 990,410 shares (Indirect, Held by Trustee of Andrew Dudum 2015 Trust Dated July 2, 2015);
Class A Common Stock — 1,194,545 shares (Indirect, Held by Trustee of AD 2022 GRAT 3 dated 11-28-2022);
Class A Common Stock — 1,286,627 shares (Indirect, Held by Trustee of AD 2021 GRAT dated 11-1-2021);
Class A Common Stock — 186,723 shares (Indirect, Held by Trustee of AD 2025 GRAT 3 dated 5-27-2025);
Class A Common Stock — 534,491 shares (Indirect, Held by Trustee of AD 2022 GRAT);
Class A Common Stock — 190,126 shares (Indirect, Held by Trustee of Dudum Family Community Property Trust);
Class A Common Stock — 321,657 shares (Indirect, Held by Trustee of AD 2021 GRAT 2 dated 11-1-2021);
Class A Common Stock — 1,584,506 shares (Indirect, Held by Trustee of AD 2023 GRAT dated 9-5-2023);
Class A Common Stock — 829,185 shares (Indirect, Held by Trustee of AD 2022 GRAT 2 dated 9/7/2022);
Class A Common Stock — 2,874,769 shares (Indirect, Held by Trustee of Dudum Family Heritage Trust UAD 8-10-2021)
Footnotes (7)
- F1. The stock option exercises and sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on August 28, 2024 by the Reporting Person.
- F2. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.08 - $50.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F3. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.08 - $49.98. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F4. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.09 - $50.04. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F5. Price reported constitutes the average weighted price of shares sold. Shares were sold at varying prices in the range of $49.07 - $50.05. The Reporting Person hereby undertakes, upon request of the Commission, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.
- F6. Prior to the Company's business combination transaction in 2021, the option represented the right to purchase 7,166,182 shares of Hims, Inc. with an exercise price of $1.10. Following the Company's business combination transaction in 2021, the option converted into the right to purchase 3,246,139 shares of the Company with an exercise price of $2.43. 100% of the shares subject to the option vested upon certain specified thresholds met in 2021.
- F7. The Stock Option was received in exchange for an option to purchase 3,583,091 shares of Class A Common Stock of Hims, Inc., with an exercise price of $1.10, in connection with the Merger. 1/48 of the shares subject to the Stock Option vest when the Reporting Person completes each month of continuous Service beginning March 13, 2020.
AI-generated analysis. How Rhea-AI works. Not financial advice.
